Real world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: The COALA project.

被引：0
|
作者：
Hitchen, Nadia
Wong, Hui-Li
Wong, Rachel
Shapiro, Jeremy David
Burge, Matthew E.
Nott, Louise M.
Lee, Belinda
Lim, Stephanie Hui-Su
Wong, Shu Fen
Caird, Susan
Wong, Vanessa
Rainey, Natalie Heather
Khattak, Adnan
Mandaliya, Hiren A.
Hayes, Theresa M.
Torres, Javier
Jalali, Azim
Campbell, Angus
Gibbs, Peter
Tie, Jeanne
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Australia
[3] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Australia
[4] Monash Univ, Eastern Hlth, Melbourne, Australia
[5] Monash Univ, Epworth Healthcare, Melbourne, Australia
[6] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Australia
[7] Cabrini Hosp, Malvern, Vic, Australia
[8] Royal Brisbane & Womens Hosp, Herston, Qld, Australia
[9] Royal Hobart Hosp, Hobart, Tas, Australia
[10] Walter & Eliza Hall Inst Med Res, Parkville, Australia
[11] Macarthur Canc Therapy Ctr, Campbelltown, NSW, Australia
[12] Barwon Hlth, Geelong, Vic, Australia
[13] Gold Coast Univ Hosp, Gold Coast, Australia
[14] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
[15] Cairns & Hinterland Hosp, Cairns, Qld, Australia
[16] Hlth Serv, Cairns, Qld, Australia
[17] Fiona Stanley Hosp, Perth, WA, Australia
[18] Edith Cowan Univ, Perth, WA, Australia
[19] Calvary Mater Newcastle, Edith St, Edith, NSW 2298, Australia
[20] South West Oncol South West Reg Canc Ctr, Warrnambool, Vic 3280, Australia
[21] Goulburn Valley Hlth, Shepparton, Vic, Australia
[22] Walter & Eliza Hall Inst Med Res, Melbourne, Australia
[23] Walter & Eliza Hall Inst Med Res, Melbourne, Australia
[24] Univ Melbourne, Melbourne, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.70
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Improvements in Clinical Outcomes for BRAFV600E-Mutant Metastatic Colorectal Cancer
    Morris, Van K.
    Bekaii-Saab, Tanios
    CLINICAL CANCER RESEARCH, 2020, 26 (17) : 4435 - 4441
  • [2] Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting
    M. Zurloh
    M. Goetz
    T. Herold
    J. Treckmann
    P. Markus
    B. Schumacher
    D. Albers
    A. Rink
    V. Rosery
    G. Zaun
    K. Kostbade
    M. Pogorzelski
    S. Ting
    H. Schmidt
    R. Stiens
    M. Wiesweg
    M. Schuler
    Stefan Kasper
    I. Virchow
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 12903 - 12912
  • [3] Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting
    Zurloh, M.
    Goetz, M.
    Herold, T.
    Treckmann, J.
    Markus, P.
    Schumacher, B.
    Albers, D.
    Rink, A.
    Rosery, V.
    Zaun, G.
    Kostbade, K.
    Pogorzelski, M.
    Ting, S.
    Schmidt, H.
    Stiens, R.
    Wiesweg, M.
    Schuler, M.
    Kasper, Stefan
    Virchow, I.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 12903 - 12912
  • [4] Chemotherapy-free Treatment of Patients with BRAFV600E-mutant metastatic Colorectal Cancer
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (06)
  • [5] Baseline characteristics of patients enrolled in the CAPSTAN study: A European retrospective study in BRAFV600E-mutant metastatic colorectal cancer patients
    Martinelli, E.
    Asselain, B.
    Cremolini, C.
    Mazard, T.
    Vidal, J.
    Virchow, I.
    Tougeron, D.
    Berradi, H.
    Castagne, C.
    Arnold, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S113 - S113
  • [6] Retrospective analysis of treatment pathways in patients with BRAFV600E-mutant metastatic colorectal carcinoma - MORSECRC
    Gerger, A.
    Eisterer, W.
    Fuxius, S.
    Bastian, S.
    Koeberle, D.
    Welslau, M.
    Akhoundova, D.
    Maas, C.
    Uhlig, J.
    Fenchel, K.
    Greil, R.
    von der Heyde, E.
    Agocs, Rhyner
    Weide, R.
    Modest, D. P.
    Fritsch, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 131 - 131
  • [7] European expert panel consensus on the clinical management of BRAFV600E-mutant metastatic colorectal cancer
    Martinelli, Erika
    Arnold, Dirk
    Cervantes, Andres
    Stintzing, Sebastian
    Van Cutsem, Eric
    Tabernero, Josep
    Taieb, Julien
    Wasan, Harpreet
    Ciardiello, Fortunato
    CANCER TREATMENT REVIEWS, 2023, 115
  • [8] BRAFV600E-Mutant V600E-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities
    Piercey, Oliver
    Tie, Jeanne
    Hollande, Frederic
    Wong, Hui-Li
    Mariadason, John
    Desai, Jayesh
    CLINICAL COLORECTAL CANCER, 2024, 23 (03) : 215 - 229
  • [9] Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC
    Gerger, Armin
    Eisterer, Wolfang
    Fuxius, Stefan
    Bastian, Sara
    Koeberle, Dieter
    Welslau, Manfred
    Sanoyan, Dilara Akhoundova
    Maas, Christian
    Uhlig, Jens
    Fenchel, Klaus
    Greil, Richard
    von der Heyde, Eyck
    Agocs, Gaelle Rhyner
    Weide, Rudolf
    Schwager, Monika
    Reichenbach, Frank
    Modest, Dominik Paul
    Fritsch, Ralph
    ANTICANCER RESEARCH, 2022, 42 (10) : 4773 - 4785
  • [10] Real-world outcomes in BRAFV600E metastatic colorectal cancer - the Glasgow experience
    Gan, H.
    White, M.
    McGaffin, G.
    Lannagan, T.
    Campbell, A.
    Graham, J.
    Sansom, O.
    Wilson, R.
    ANNALS OF ONCOLOGY, 2022, 33 : S259 - S260
12345